The effect of curcumin on metabolic indicators in women with polycystic ovarian syndrome
Phase 3
Recruiting
- Conditions
- polycystic ovary syndrome.Polycystic ovarian syndromeE28.2
- Registration Number
- IRCT20120718010324N51
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 54
Inclusion Criteria
Willingness to participate in the study
Having sufficient literacy to complete the questionnaire or the presence of a literate person in the family
Having polycystic ovarian syndrome
BMI Between 25 and 40
Exclusion Criteria
Having other androgenic disorders, such as adrenal hyperplasia or a androgen secreting tumors
Having thyroid gland diseases
having Cushing's syndrome
Taking hormonal contraceptives currently or using hormonal therapy
Pregnancy or breastfeeding
Previous surgery on one or both ovaries
Smoking and drinking alcohol
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of metabolic factors (fasting insulin, fasting blood glucose, LDL, HDL, and cholesterol). Timepoint: Before and 12 weeks after intervention with drug/placebo. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method Hirsutism Score. Timepoint: Before and 12 weeks after intervention with drug/placebo. Method of measurement: Ferriman–Gallwey criteria.;Anthropometric indices (waist circumference, hip circumference and body mass index). Timepoint: Before and 12 weeks after intervention with drug/placebo. Method of measurement: Measuring with centimeter and scale.;Menstrual status. Timepoint: Before and 12 weeks after intervention with drug/placebo. Method of measurement: Menstrual characteristics questionnaire.